The role of p53 in cancer drug resistance and targeted chemotherapy
about
Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets.Phytochemicals Approach for Developing Cancer Immunotherapeutics.Altholactone Inhibits NF-κB and STAT3 Activation and Induces Reactive Oxygen Species-Mediated Apoptosis in Prostate Cancer DU145 Cells.Exploring the Human-Nipah Virus Protein-Protein Interactome.Synaptotagmin-7 is overexpressed in hepatocellular carcinoma and regulates hepatocellular carcinoma cell proliferation via Chk1-p53 signaling.Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients.TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.Risk Factors and Preventions of Breast Cancer.Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma.PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation.P53-derived hybrid peptides induce apoptosis of synovial fibroblasts in the rheumatoid joint.Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies.Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma.Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas.Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression.Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1.MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer.Aloe-emodin as drug candidate for cancer therapy.Proteomics Analysis to Assess the Role of Mitochondria in BRCA1-Mediated Breast Tumorigenesis.Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology.Differential mRNA expression of the main apoptotic proteins in normal and malignant cells and its relation to in vitro resistance.Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide.Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells.Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.Predicting Tumor Sensitivity to Chemotherapeutic Drugs in Oral Squamous Cell Carcinoma Patients
P2860
Q33753279-773E911D-2C0D-4D16-ACA5-993CF5AC17BAQ33809573-A7573CE9-BF63-4878-AB86-31DC5D28819CQ38717326-C7F096A5-70B5-4D44-874C-B14784D8058CQ40042457-7187C99F-C927-43C4-A672-52F8F9B7739EQ41633930-AFBDAD06-3E2D-4AB1-BE1F-4060B0531CBDQ43203015-F5A770FC-210C-466C-8997-E50454B8B040Q46317683-00284555-6589-406A-9454-ABA7B659E2B5Q47100005-2C8EADFA-EB57-4E5F-B3BF-CAB5874A2A55Q47110143-0CD6D5EB-AAAC-4D91-9658-2CE7ECC891DFQ47154860-8C562C7C-7DA3-4D0C-9C25-EF72217BC84CQ48507317-0680499E-8748-407F-9B11-0E20B66DB33CQ48518814-A2BF2947-4005-45EB-8FFD-568C090905A9Q49182137-BFCC9F7C-FEC7-416E-9696-AAD815B5B39EQ49233795-ADCFB92B-3819-434F-B957-5E6D6431C576Q49688722-875E92C3-CB50-4D21-A265-17A98066B274Q49882954-D3138CFF-FCDE-4EE1-8F78-45AB10210926Q49952370-8804844A-2270-4C4F-92B8-C9168848D921Q50072310-FAE9E61B-1BE0-4106-B500-0477304835E4Q52715777-5DF82245-D4D6-4C64-9B34-8634BE811899Q53176675-34E7F6B3-6B4E-47F8-A52E-D3F148AE7C4EQ53702218-431B9B32-DA23-4740-B421-4264FC22DE81Q53703877-03C0C6C8-0E6F-47DA-A2A4-13D2F8BA7E62Q55327757-7899EFA4-A806-4162-B1A0-31F30FE06AEBQ55504431-CFAD547C-7425-4E51-A938-60E4427C59A3Q55504502-577B61DD-0993-443F-9434-FC067B23F4CDQ57811412-30055CAE-C1DF-4005-A4A4-3AEE099F817D
P2860
The role of p53 in cancer drug resistance and targeted chemotherapy
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The role of p53 in cancer drug resistance and targeted chemotherapy
@ast
The role of p53 in cancer drug resistance and targeted chemotherapy
@en
The role of p53 in cancer drug resistance and targeted chemotherapy
@nl
type
label
The role of p53 in cancer drug resistance and targeted chemotherapy
@ast
The role of p53 in cancer drug resistance and targeted chemotherapy
@en
The role of p53 in cancer drug resistance and targeted chemotherapy
@nl
prefLabel
The role of p53 in cancer drug resistance and targeted chemotherapy
@ast
The role of p53 in cancer drug resistance and targeted chemotherapy
@en
The role of p53 in cancer drug resistance and targeted chemotherapy
@nl
P2093
P2860
P921
P356
P1433
P1476
The role of p53 in cancer drug resistance and targeted chemotherapy
@en
P2093
André Mohr
Karin Hientz
Thomas Efferth
P2860
P304
P356
10.18632/ONCOTARGET.13475
P407
P5008
P577
2017-01-01T00:00:00Z